These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10512086)

  • 21. Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'.
    Haddad PM; Devarajan S; Dursun SM
    J Psychopharmacol; 2001 Jun; 15(2):139-41. PubMed ID: 11448088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs.
    Fava GA; Cosci F
    J Clin Psychiatry; 2019 Nov; 80(6):. PubMed ID: 31774947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models.
    Zabegalov KN; Kolesnikova TO; Khatsko SL; Volgin AD; Yakovlev OA; Amstislavskaya TG; Alekseeva PA; Meshalkina DA; Friend AJ; Bao W; Demin KA; Gainetdinov RR; Kalueff AV
    Eur J Pharmacol; 2018 Jun; 829():129-140. PubMed ID: 29627310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].
    Chamorro García L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1991; 19(6):298-303. PubMed ID: 1687233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Exacerbation of an affective psychosis after terminating a decade of benzodiazepine treatment. Which therapeutic procedure is sensible?].
    Soyka M; Lehle R; Hippius H
    Nervenarzt; 1994 Sep; 65(9):628-32. PubMed ID: 7991010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long day's journey into night: women and prescription drug abuse.
    Ogur B
    Women Health; 1986; 11(1):99-115. PubMed ID: 2874664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress and addiction.
    Kosten TR
    Am J Psychiatry; 2011 Jun; 168(6):566-8. PubMed ID: 21642477
    [No Abstract]   [Full Text] [Related]  

  • 29. [Other sedatives and hypnotics-related disorders].
    Matsumoto C; Nakamura J
    Ryoikibetsu Shokogun Shirizu; 2003; (40):497-500. PubMed ID: 14626169
    [No Abstract]   [Full Text] [Related]  

  • 30. Stress and addiction: a dynamic interplay of genes, environment, and drug intake.
    Sinha R
    Biol Psychiatry; 2009 Jul; 66(2):100-1. PubMed ID: 19555787
    [No Abstract]   [Full Text] [Related]  

  • 31. Manic symptoms as a symptom of antidepressant discontinuation syndrome in a child.
    Özcan Ö; Özdemir S; Kütük ÖM
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):507-8. PubMed ID: 24024536
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipsychotic discontinuation syndromes: a narrative review of the evidence and its integration into Australian mental health nursing textbooks.
    Salomon C; Hamilton B
    Int J Ment Health Nurs; 2014 Feb; 23(1):69-78. PubMed ID: 23211033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.
    Chouinard G; Chouinard VA
    Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939
    [No Abstract]   [Full Text] [Related]  

  • 34. Antidepressant discontinuation reactions.
    Haddad P; Lejoyeux M; Young A
    BMJ; 1998 Apr; 316(7138):1105-6. PubMed ID: 9552943
    [No Abstract]   [Full Text] [Related]  

  • 35. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant discontinuation syndrome.
    Warner CH; Bobo W; Warner C; Reid S; Rachal J
    Am Fam Physician; 2006 Aug; 74(3):449-56. PubMed ID: 16913164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "All roads lead to medication?" Qualitative responses from an Australian first-person survey of antipsychotic discontinuation.
    Salomon C; Hamilton B
    Psychiatr Rehabil J; 2013 Sep; 36(3):160-5. PubMed ID: 23815172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The dangers of the sudden discontinuation of drugs].
    de Graeff PA
    Ned Tijdschr Geneeskd; 1985 Jun; 129(22):1034-9. PubMed ID: 2861575
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs.
    Oderda LH; Young JR; Asche CV; Pepper GA
    Ann Pharmacother; 2012; 46(7-8):917-28. PubMed ID: 22811347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Psychotropic agents may induce de novo nonconvulsive status epilepticus].
    Yoshino A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Feb; 20(1):1-10. PubMed ID: 10890017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.